DiaSorin Inc has received Food and Drug Administration clearance for its LIAISON® 25-hydroxy Vitamin D and LIAISON N-TACT™ PTH assays. Testing for 25-hydroxy Vitamin D and PTH provides physicians with definitive analysis of nutritional Vitamin D deficiency. The LIAISON system can handle 180 tests per hour.
“We are proud to be the leader in bone and mineral diagnostics with the introduction of DiaSorin’s third generation of 25-hydroxy Vitamin D testing,” says Stephen P. Gouze, president and general manager of DiaSorin Inc. “LIAISON offers the only antibody-based Vitamin D assay available in an automated, random access chemiluminescence platform, providing the same consistent results physicians have seen from DiaSorin’s radioimmunoassay for over a decade. Patients benefit from the rapid results and world-class assay reliability of the LIAISON system. Laboratories benefit from high throughput and complete walk-away automation from extraction through data output.”
Over 800 LIAISON systems are in use worldwide with a menu of more than 60 diagnostic tests, including hepatitis, infectious disease, and autoimmune assays.
DiaSorin Inc
(651) 439-9710; www.diasorin.com
